TXMD icon

TherapeuticsMD
TXMD

Overview Fund Trends Analyst Outlook Journalist POV

53 hedge funds and large institutions have $20.3M invested in TherapeuticsMD in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less capital invested

Capital invested by funds: $ → $

57% less funds holding

Funds holding: 124 → 53 (-71)

85% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 82

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.21M
Puts
$5.61M
Net Calls
Net Calls Change

Top Buyers

1
+$6.82M
2
+$843K
3
+$694K
4
Millennium Management
Millennium Management
New York
+$571K
5
GF
Gabelli Funds
New York
+$338K

Top Sellers

1
-$3.65M
2
-$2.35M
3
-$1.31M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.2M
5
State Street
State Street
Massachusetts
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4 5